Concepedia

Karan Mediratta

KM

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2020

Affiliations

University of Ottawa(Current)

Ottawa Hospital Research Institute

Health Canada

Ottawa Hospital

Institute of Infection and Immunity

Karan Mediratta is an author at University of Ottawa specializing in oncology, bioreactor design, and chemotherapy.

ORCID

Publications per year

2020–2024

3

Publications

3

A clinically relevant large‐scale biomanufacturing workflow to produce natural killer cells and natural killer cell‐derived extracellular vesicles for cancer immunotherapy

Frédéric St-Denis Bissonnette, Sarah E. Cummings, Shirley Qiu et al. · Journal of Extracellular Vesicles · 2023 · 28 citations · Full text

, , +16

Targeting Hypoxia Sensitizes TNBC to Cisplatin and Promotes Inhibition of Both Bulk and Cancer Stem Cells

Andrew Sulaiman, Sarah McGarry, Jason Chambers et al. · International Journal of Molecular Sciences · 2020 · 16 citations · Full text

, , +17

Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model

Karan Mediratta, Sara El‐Sahli, Marie Marotel et al. · Frontiers in Immunology · 2024 · 13 citations · Full text

, , +17

1–3 of 3